// App-Quantinova.ai

TCT-15 : Results of the Primary Endpoint of the PLATINUM PLUS Trial: A Prospective, Randomized, Multi-center Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in a Population of Unrestricted Patients

Researchers

Presenter

  • Jean Fajadet

Principal Investigators

  • Eulogio J. Garcia

  • David Hildick-Smith

  • Franz-Josef Neumann

  • Anna Sonia Petronio

  • Mark S. Spence

  • Jochen Wohrle

  • Azfar Zaman

  • Simon Elhadad

  • Sigmund Silber

Medical Centers

  • hopital, lagny sur marne, France

  • Clinique Pasteur, Toulouse, France

  • Universitaets-Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany

  • University of Ulm, Ulm, Germany

  • Royal Sussex County Hospital, Brighton, United Kingdom

  • Heart Center at the Isar, Munich, Germany

  • Royal Hospitals, Belfast, United Kingdom

  • University of Pavia, Pavia, Italy

Locations

  • Italy

  • Germany

  • Spain

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Hypercholesterolemia, Familial, 1

  • Hypertension

  • Venous thrombosis

  • Coronary Artery Disease

  • Diabetes

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • Promus Element

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved